Published in J Am Acad Dermatol on December 28, 2012
Comment on 'A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis'. J Am Acad Dermatol (2014) 1.07
Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96
Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis. Mediators Inflamm (2013) 0.85
Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag (2016) 0.79
A response to "Comment on 'A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis'". J Am Acad Dermatol (2014) 0.75
[Cutaneous manifestations of sarcoidosis]. Z Rheumatol (2017) 0.75
Advanced age exacerbates the pulmonary inflammatory response after lipopolysaccharide exposure. Crit Care Med (2007) 1.22
Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics (2011) 1.06
Fatal rhino-orbito-cerebral mucormycosis in a patient with liver disease. J Am Acad Dermatol (2011) 0.79
Removal time and efficacy of Riddell Quick Release Face Guard Attachment System side clips during 1 football season. J Athl Train (2012) 0.75
Patient-provider communication, concordance, and ratings of care in dermatology: Results of a cross-sectional study. Dermatol Online J (2016) 0.75
Movement Intensity and Caloric Expenditure Differences Between Walking and Pickleball: 766 Board #82 June 1, 2: 00 PM - 3: 30 PM. Med Sci Sports Exerc (2016) 0.75
Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review. Dermatol Surg (2017) 0.75
Quality Measures in Home Care: How Can We Prepare? Home Healthc Now (2015) 0.75